Metropolis Healthcare Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Metropolis Healthcare Share Price

520.15-4.31 (-0.82%)

Closed
As On: 11 Jun, 2026, 03:31 PM IST
As On: 11 Jun, 2026, 03:52 PM IST

Sector: Hospitals & All...
Industry: Diagnostics

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	522.10
High	537.30
Low	515.00
Prev Close	524.45
Volume	1,22,888
VWAP(₹)	524.37

Key Metrics

PE Ratio(x)	56.75
EPS - TTM(₹)	9.17
MCap(₹ Cr.)	10,784.15
MCap Rank	15
PB Ratio(x)	7.13
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	600.00
52W Low(₹)	412.25
MCap/Sales	5.46
Beta(1 Month)	0.54
BV/Share(₹)	73.53

Metropolis Health share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 24.15% outperformed its 3 year CAGR of 12.7%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 1.49% of its operating revenues towards interest expenses and 22.93% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Metropolis Health Share Price Update
Metropolis Healthcare Ltd. share price moved down by -0.82% from its previous close of Rs 524.45. Metropolis Healthcare Ltd. stock last traded price is 520.15
Share Price Value
Today/Current/Last 520.15517.50
Previous Day 524.45524.35

Found Insights useful?

Metropolis Health Share Price Returns

1 Day	-0.82%
1 Month	-7.1%
3 Months	13.26%
1 Year	23.2%
3 Years	62.62%
5 Years	-30.01%

Metropolis Health Share Recommendations

Mean recosCurrent

BUY

18 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	7	7	7	7
Buy	7	7	7	7
Hold	2	2	2	2
Sell	2	2	2	2
Strong Sell	-	-	-	-
# Analysts	18	18	18	18

Recent Recos

Target₹2250
OrganizationICICI Securities
BUY

Target₹2335
OrganizationICICI Securities
ADD

Target₹2279
OrganizationICICI Securities
ADD

View all Stock Recommendations

News & Analysis

View all Metropolis Health Share News & Announcements

Financials

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	414.93	430.08	393.58	352.26	325.32
Total Income Growth (%)	-3.52	9.27	11.73	8.28	-7.82
Total Expenses	352.04	353.37	327.15	311.62	278.45
Total Expenses Growth (%)	-0.38	8.02	4.98	11.91	-2.89
EBIT	62.89	76.71	66.43	40.64	46.87
EBIT Growth (%)	-18.02	15.47	63.45	-13.28	-29.19
Profit after Tax (PAT)	41.39	52.67	45.06	29.14	31.36
PAT Growth (%)	-21.42	16.88	54.63	-7.08	-32.59
EBIT Margin (%)	15.16	17.84	16.88	11.54	14.41
Net Profit Margin (%)	9.97	12.25	11.45	8.27	9.64
Basic EPS (₹)	7.99	10.17	8.70	5.69	6.12

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	337.00	358.23	326.41	319.55	299.91
Total Income Growth (%)	-5.93	9.75	2.15	6.55	-7.77
Total Expenses	290.31	292.15	274.44	286.49	258.63
Total Expenses Growth (%)	-0.63	6.45	-4.21	10.77	-2.61
EBIT	46.69	66.09	51.98	33.06	41.29
EBIT Growth (%)	-29.35	27.15	57.21	-19.92	-30.73
Profit after Tax (PAT)	32.03	46.63	35.58	23.85	27.40
PAT Growth (%)	-31.31	31.06	49.19	-12.97	-35.16
EBIT Margin (%)	13.85	18.45	15.92	10.35	13.77
Net Profit Margin (%)	9.51	13.02	10.90	7.46	9.14
Basic EPS (₹)	6.18	9.00	6.87	4.65	5.35

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,346.32	1,216.83	1,163.43	1,245.96	1,010.03
Total Revenue Growth (%)	10.64	4.59	-6.62	23.36	16.77
Total Expenses	1,155.46	1,042.14	975.93	968.51	765.71
Total Expenses Growth (%)	10.87	6.78	0.77	26.49	14.08
Profit after Tax (PAT)	144.97	127.82	142.88	214.18	183.10
PAT Growth (%)	13.42	-10.54	-33.29	16.98	43.80
Operating Profit Margin (%)	15.73	16.33	18.66	24.19	25.26
Net Profit Margin (%)	10.89	10.58	12.44	17.43	18.34
Basic EPS (₹)	28.29	24.95	27.91	41.87	35.97

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,233.59	1,115.42	1,087.32	1,133.13	864.76
Total Revenue Growth (%)	10.59	2.58	-4.04	31.03	24.49
Total Expenses	1,071.57	958.01	908.38	887.25	618.71
Total Expenses Growth (%)	11.85	5.46	2.38	43.40	16.71
Profit after Tax (PAT)	124.80	115.89	138.95	192.24	197.56
PAT Growth (%)	7.69	-16.59	-27.72	-2.69	76.30
Operating Profit Margin (%)	14.81	16.28	19.28	23.73	30.85
Net Profit Margin (%)	10.25	10.50	13.03	17.20	24.20
Basic EPS (₹)	24.35	22.63	27.14	37.58	38.81

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 24.15% outperformed its 3 year CAGR of 12.7%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 1.49% of its operating revenues towards interest expenses and 22.93% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,867.34	1,555.06	1,501.61	1,530.29	1,004.42
Total Assets Growth (%)	20.08	3.56	-1.87	52.36	33.52
Total Liabilities	532.70	455.79	510.90	642.13	296.35
Total Liabilities Growth (%)	16.87	-10.79	-20.44	116.68	30.51
Total Equity	1,334.64	1,099.27	990.71	888.17	708.07
Total Equity Growth (%)	21.41	10.96	11.55	25.44	34.83
Current Ratio (x)	1.18	1.28	1.14	1.30	2.98
Total Debt to Equity (x)	0.01	0.00	0.08	0.29	0.00
Contingent Liabilities	15.45	10.28	4.99	12.52	26.79

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	1,684.90	1,472.70	1,434.29	1,344.54	933.44
Total Assets Growth (%)	14.41	2.68	6.68	44.04	35.62
Total Liabilities	440.46	441.51	498.28	520.41	224.51
Total Liabilities Growth (%)	-0.24	-11.39	-4.25	131.80	27.63
Total Equity	1,244.45	1,031.19	936.02	824.13	708.93
Total Equity Growth (%)	20.68	10.17	13.58	16.25	38.36
Current Ratio (x)	1.05	1.16	1.05	1.24	3.27
Total Debt to Equity (x)	0.00	0.00	0.09	0.31	0.00
Contingent Liabilities	14.41	9.42	4.20	12.11	21.70

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	262.75	264.07	247.09	253.27	249.03
Net Cash used in Investing Activities	-201.06	-89.41	46.79	-737.57	61.70
Net Cash flow from Financing Activities	-86.63	-181.20	-292.33	162.52	-32.69
Net Cash Flow	-23.14	-6.21	2.85	-320.61	279.42
Closing Cash & Cash Equivalent	39.48	62.62	68.83	65.98	386.59
Closing Cash & Cash Equivalent Growth (%)	-36.96	-9.03	4.32	-82.93	260.71
Total Debt/ CFO (x)	0.05	0.00	0.32	1.02	0.00

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	275.01	269.01	237.74	237.15	202.50
Net Cash used in Investing Activities	-196.09	-81.00	46.72	-733.79	73.53
Net Cash flow from Financing Activities	-84.50	-183.00	-287.87	173.14	-26.33
Net Cash Flow	-5.90	4.50	-3.40	-323.50	249.70
Closing Cash & Cash Equivalent	22.68	28.59	24.09	24.18	317.13
Closing Cash & Cash Equivalent Growth (%)	-20.65	18.68	-0.40	-92.37	370.30
Total Debt/ CFO (x)	0.00	0.00	0.35	1.09	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 223.12 cr for investing activities which is an YoY increase of 10.98%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	10.89	11.66	14.45	24.11	25.91
Return on Capital Employed (%)	13.31	15.06	17.32	24.18	31.49
Return on Assets (%)	7.76	8.21	9.51	13.99	18.22
Interest Coverage Ratio (x)	17.13	12.94	11.32	18.26	32.40
Asset Turnover Ratio (x)	0.78	0.79	0.76	0.95	99.36
Price to Earnings (x)	55.87	69.44	44.84	48.78	62.89
Price to Book (x)	6.08	8.07	6.47	11.73	16.21
EV/EBITDA (x)	25.35	30.09	21.03	29.17	37.03
EBITDA Margin (%)	23.89	24.15	26.43	29.34	29.86

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	10.02	11.23	14.84	23.32	27.86
Return on Capital Employed (%)	12.52	14.51	17.41	24.74	32.47
Return on Assets (%)	7.40	7.86	9.68	14.29	21.16
Interest Coverage Ratio (x)	15.62	12.11	10.89	16.61	43.60
Asset Turnover Ratio (x)	0.77	0.76	0.77	0.98	87.43
Price to Earnings (x)	64.94	76.34	46.08	54.35	58.14
Price to Book (x)	6.50	8.58	6.83	12.65	16.16
EV/EBITDA (x)	28.29	32.58	22.15	32.92	38.61
EBITDA Margin (%)	23.44	24.51	27.25	28.74	35.29

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
Heikin-Ashi Changeover
Bearish indication on daily chart
Prev. Close Price
531.21
LTP
520.15
Formed on:

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Metropolis Health	56.75	7.07	12.55	16.22	8.88	12.70	17.78	11.61	9.19	1.40	0.01	0.05
Dr Lal Pathlabs	52.89	10.51	20.12	26.78	16.04	11.51	26.13	18.45	30.24	3.48	0.00	0.00
Vijaya Diagnostic	76.20	13.75	18.07	19.22	11.47	20.60	32.65	21.24	16.81	2.60	0.00	0.00
Thyrocare Tech.	50.71	14.11	27.84	34.59	21.81	16.32	26.59	19.47	10.27	3.39	0.00	0.00
Krsnaa Diagnostics	17.05	1.76	10.34	10.64	5.56	17.05	21.32	13.13	31.29	2.68	0.55	3.73
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings

Category	No. of Shares	Percentage	% Change QoQ
Promoters	10,13,11,984	48.87 %	-0.01
Pledge	12,00,000	1.18 %	0.00
FII	2,16,16,794	10.43 %	-1.25
DII	7,42,11,660	35.80 %	1.07
MF	6,89,93,492	33.28 %	1.06
Others	1,01,87,330	4.90 %	0.18

QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 48.87 48.88 48.89 48.89
Pledge 1.18 1.18 1.18 1.18
FII 10.43 11.68 12.52 12.83
DII 35.80 34.73 33.10 32.40
Mutual Funds 33.28 32.22 30.69 29.81
Others 4.90 4.71 5.49 5.87

Mutual Funds Ownership

MF Ownership as on 30 April 2026

HDFC Focused Direct-G
Equity: Flexi Cap
5
- 324.02
  Amount Invested (in Cr.)
- 1.24%
  % of AUM
- 0.00
  % Change (MoM basis)
HDFC Flexi Cap Direct-G
Equity: Flexi Cap
5
- 309.73
  Amount Invested (in Cr.)
- 0.31%
  % of AUM
- 0.00
  % Change (MoM basis)
Kotak Small Cap Direct-G
Equity: Small Cap
2
- 303.62
  Amount Invested (in Cr.)
- 1.74%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Metropolis Health Top Searches

Corporate Actions

Recent
Interim Dividend
50%
May 13, 2026
Final
50%
May 13, 2026
Board Meeting
Audited Results & Interim Dividend
May 07, 2026

Announced on	Meeting on
May 07, 2026	May 13, 2026
Audited Results & Interim Dividend
Jan 30, 2026	Feb 04, 2026
Quarterly Results & Bonus issue
Oct 29, 2025	Nov 04, 2025
Quarterly Results & Interim Dividend
Jul 31, 2025	Aug 07, 2025
Quarterly Results
May 05, 2025	May 13, 2025
Audited Results

Dividends
Announced on Ex-Date Dividend%
May 13, 2026 May 19, 2026 50%
Nov 06, 2025 Nov 11, 2025 200%
Nov 06, 2023 Nov 17, 2023 200%
Feb 07, 2023 Feb 23, 2023 400%
May 13, 2026 - 50%
Bonus
Announced on Ex-Date
Feb 04, 2026 Mar 20, 2026
Bonus Ratio: 3 share(s) for every 1 shares held
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Feb 06, 2026 Mar 10, 2026
-
Jul 22, 2025 Aug 13, 2025
-
May 16, 2025 Jun 16, 2025
-
Jan 10, 2025 Feb 11, 2025
-
Jul 31, 2024 Aug 21, 2024
-

About Metropolis Health

Metropolis Healthcare Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 10,784.15 Crore) operating in Hospitals & Allied Services sector.

Metropolis Healthcare Ltd. key Products/Revenue Segments include Service Income for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 432.84 Crore, up 4.32 % from last quarter Total Income of Rs 414.93 Crore and up 22.88 % from last year same quarter Total Income of Rs 352.26 Crore. Company has reported net profit after tax of Rs 50.96 Crore in latest quarter.

The company’s top management includes Mrs.Ameera Sushil Shah, Mr.Surendran Chemmenkotil, Dr.Aparna Rajadhyaksha, Mr.Hemant Sachdev, Dr.Sushil Kanubhai Shah, Ms.Purvi Sheth, Mr.Sanjay Bhatnagar, Mr.Subramanian Ranganathan, Mr.Vivek Gambhir, Mr.Sameer Patel, Mr.Kamlesh Kulkarni. Company has BSR & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 20.73 Crore shares outstanding.

Metropolis Health Share Price Today is Rs. 520.15. On previous day, the Metropolis Health Share Price (NSE) closed at Rs. 535.55, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 48.87% of the stake in Metropolis Health shares, out of which 1.18% was pledged. On the same date, foreign institutional investors' (FII) holdings of Metropolis Health stocks was 10.43% as compared to 11.68% in Dec 2025 with decrease of 1.25%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 35.8% as compared to 34.73% in Dec 2025 with increase of 1.07%. Out of the total DII holdings in Metropolis Health shares 33.28% was held by mutual funds. The rest including public held is 4.9%. Metropolis Health stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Metropolis Health Dividend: Ever since 2006, Metropolis Health dividends has been paid out around 8 times. As on 11 Jun, 2026, 03:31 PM IST, The overall dividend yield for Metropolis Health stands at 0.0%. The last dividend paid was on May 19, 2026 (Rs. 1.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 9.17.

Metropolis Health Bonus: The most recent bonus issue had been in year March 20, 2026 around 0 years ago at 1 : 3 ratio. The first bonus issue was announced in Feb 2026.

Stock Forecast:
After showing 432.84 Cr. of sales and 4.32% of quarterly net profit, there have been multiple ups and downs in the Metropolis Health stock prices in the past few weeks. For example, Metropolis Health stock price on 3rd of June 2026 was around Rs. 536.15. Metropolis Health share price now stands at an average of Rs. 520.15. Judging by last week's performance, stock is in down trend.

Metropolis Health has a median target price of Rs. 600.83 in 12 months by 18 analysts. They have provided a high estimate of Rs. 680.25 and low estimate of Rs. 500.0 for Metropolis Health share.

Historical Prices and Performance:
Metropolis Health, incorporated in 2006 is a Mid Cap company (with a market cap of Rs. 10873.3) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Metropolis Health stock was 12.55%, 10.89%, 11.66%, 14.45% and 24.11% respectively.
The Metropolis Health share gave a 3 year return of 63.96% as compared to Nifty 50 which gave a return of 25.06%.
Metropolis Health announced 50.0% final dividend on May 19, 2026.

Key Metrics:
PE Ratio of Metropolis Health is 57.22
Prices/Sales Ratio of Metropolis Health is 5.46
Price/Book Ratio of Metropolis Health is 7.13

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Metropolis Health, major competitors and peers include Dr Lal Pathlabs, Vijaya Diagnostic, Thyrocare Tech. and Krsnaa Diagnostics. As of Dec 2025, the dividend yield of Metropolis Health stands at 0.0% while Dr Lal Pathlabs, Vijaya Diagnostic, Thyrocare Tech. and Krsnaa Diagnostics stand at 1.53%, 0.16%, 2.63% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 57.22 and 7.13 respectively.

Recommendations:
The current total number of analysts covering the stock stands at 18, Three months ago this number stood at 18. Out of total, 7 analyst have a'Strong Buy' reco, 7 analyst have a'Buy' reco, 2 analyst have a'Hold' reco, 2 analyst have a'Sell' reco.

Mean recommendations by 18 analyst stand at'Buy'.

Leadership of Metropolis Health :
Surendran Chemmenkotil is Chief Executive Officer
Sameer Patel is Chief Financial Officer
Kamlesh Kulkarni is Head - Legal & Co. Secretary
Ameera Sushil Shah is Exe.Chairman & W T D
Hemant Sachdev is Non Exe.Non Ind.Director
Aparna Rajadhyaksha is Non Exe.Non Ind.Director
Sushil Kanubhai Shah is Non Executive Director
Sanjay Bhatnagar is Independent Director
Subramanian Ranganathan is Independent Director
Purvi Sheth is Independent Director
Vivek Gambhir is Independent Director

Show More

Industry

Key Indices Listed On

Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap, BSE Healthcare

Address

4th Floor, East Wing,Plot-254 B, Nirlon House,Mumbai, Maharashtra - 400030

Contact

secretarial@metropolisindia.com

http://www.metropolisindia.com

Executive Leadership

AS

Ameera Sushil Shah

Exe.Chairman & W T D

SC

Surendran Chemmenkotil

Chief Executive Officer

AR

Aparna Rajadhyaksha

Non Exe.Non Ind.Director

HS

Hemant Sachdev

Non Exe.Non Ind.Director

Show More

Auditors

BSR & Co. LLP

FAQs about Metropolis Health share

1. What is Metropolis Health share price and what are the returns for Metropolis Health share?
Metropolis Health share price is Rs 520.15 as on 11 Jun, 2026, 03:31 PM IST. Metropolis Health share price is down by 0.82% based on previous share price of Rs 535.55. Metropolis Health share price trend:
- Last 12 Months: Metropolis Health share price moved up 23.20%
- Last 3 Years: Metropolis Health Share price moved up by 62.62%
2. What is the PE & PB ratio of Metropolis Health?
The PE ratio of Metropolis Health stands at 57.22, while the PB ratio is 7.13.
3. What is 52 week high/low of Metropolis Health share price?
52 Week high of Metropolis Health share is Rs 600.00 while 52 week low is Rs 412.25
4. What's the market capitalization of Metropolis Health?
Market Capitalization of Metropolis Health stock is Rs 10,784.15 Cr.
5. What are the returns for Metropolis Health share?
Return Performance of Metropolis Health Shares:
- 1 Week: Metropolis Health share price moved down by 4.41%

Top Gainers

As on 03:59 PM | 11 Jun 2026

Aegis Logistics

925.90

124.90 (15.60%)

111.45

8.52 (8.28%)

DOMS Industries

2,255.40

136.81 (6.46%)

Blue Jet Healthcare

498.45

28.70 (6.11%)

1,923.80

90.80 (4.96%)

Top Losers

As on 03:59 PM | 11 Jun 2026

Balkrishna Ind.

1,974.00

-109.20 (-5.25%)

1,133.10

-60.31 (-5.06%)

155.70

-7.93 (-4.85%)

166.91

-8.00 (-4.57%)

Adani Transmission

1,466.70

-68.90 (-4.49%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.